The theme of this year’s Neuro-Oncology Special Interest Group session is Neuroimaging for Brain Tumors. Advances over the past decade have expanded neuroimaging beyond structural techniques to include physiologic and molecular approaches that provide insight into tumor biology. Modalities such as perfusion imaging and amino acid PET are enhancing diagnostic accuracy and enabling earlier, more […] Read More
Neuro-ophthalmologists and neuro-otologists diagnose and manage complex disorders of the visual and vestibular systems. Advancing care requires translating laboratory discoveries into clinically meaningful tools, therapies, and patient-centered outcomes. In this Special Interest Group session, From Bench to Bedside in Neuro-ophthalmology and Neuro-vestibular Disease, experts will present three complementary perspectives: technology-enabled, real-world measures of vestibular function; […] Read More
This session will highlight recent advances in sleep and circadian science, spanning foundational mechanisms to clinical applications. Faculty will review the impact of sleep and circadian dysfunction in neurodevelopmental disorders, including associated clinical features and implications for patient care. The session will also address current and emerging approaches to diagnosis and management, with a focus […] Read More
This session will examine the management of patients with concomitant traumatic brain injury (TBI) and spinal cord injury (SCI), drawing on current clinical and translational research. With co-occurrence rates as high as 30–50% in SCI and approximately 12.5% in TBI, this “dual diagnosis” presents significant challenges across the continuum of care—from neurocritical care to neurorehabilitation. […] Read More
This session will highlight the fundamental principles of CAR-T therapy, differentiate safety and tolerability profile of CAR-T therapies in cancer versus autoimmune disorders, and evaluate the emerging therapeutic applications of CAR-T in neuromuscular disorders, particularly in myasthenia gravis and myositis. Attendees will gain practical clinical insights, understand evolving safety frameworks, and be prepared to assess […] Read More
Cerebrovascular disease remains a rapidly evolving field, with ongoing advances shaping prevention, treatment, and outcomes. This session will highlight late-breaking developments in secondary stroke prevention, intracerebral hemorrhage (ICH), and sex-specific risk factors in stroke. Presentations will examine factors unique to women that influence stroke risk, treatment, and participation in research, with particular emphasis on pregnancy […] Read More
Comorbidities play a significant role in the progression and chronification of migraine and other headache disorders. Understanding these relationships can provide insight into underlying pathophysiology and inform more comprehensive treatment approaches. This session will explore key comorbidities—including hormonal influences (e.g., pituitary disorders), pain and sleep disorders, women’s health considerations, and vascular disease—and discuss their impact […] Read More
The 2026 Movement Disorders Special Interest Group session highlights a shift from phenotype-based classification to biologically driven, mechanism-based frameworks that are shaping therapeutic development. Advances in molecular genetics, proteinopathies, and systems neuroscience are redefining disease heterogeneity, progression, and treatment response across disorders such as dystonia, Parkinson’s disease (PD), and progressive supranuclear palsy (PSP). This session […] Read More
Music-based interventions are increasingly used as adjunctive therapies in the management of a broad range of neurological conditions. This session will focus on the clinical application of music and rhythm to support motor, cognitive, and communicative function, as well as overall quality of life. Faculty will review practical approaches to incorporating music-based therapies into patient […] Read More
Behavioral neurology is entering a new era in which advances in precision medicine, digital phenotyping, artificial intelligence (AI), and scalable care delivery models are transforming how clinicians identify and treat neurologic and neurobehavioral disorders. As patient populations grow and access to specialty care remains limited, there is an urgent need for high-throughput approaches that enhance […] Read More